New Research: Life Sciences Organizations are Ahead of the Curve, but Vulnerabilities Persist

Originally published by Code42. Written by Clea Ostendorf. From HIPAA regulations, to lost business opportunities, to stolen IP and trade secrets, organizations in the Life Sciences sector stand to lose a great deal to Insider Risk. Though all sectors are faced with the threat of data loss from insiders, those in the Life Sciences – medical device manufacturers, biotech, and pharma companies – are tasked with protecting massive amounts of both proprietary and sensitive data. Without the prope...

business code42 data data loss deal great hipaa insider insider risk life loss lost opportunities organizations regulations research risk secrets sector sectors stolen threat trade trade secrets vulnerabilities written